Osiris sets up division for biotech devices

08/5/2009 | American City Business Journals

Osiris Therapeutics established a biosurgery unit that focuses on developing and commercializing biotech devices for orthopedic procedures. The division comprises doctors, scientists, and regulatory and manufacturing experts who developed Osteocel, a line of medical devices sold by Osiris to NuVasive for $85 million.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC